Periodontal disease: The influence of metabolic syndrome

Nutrition and Metabolism

Volumn 9, Issue , 2012, Pages

  Marchetti, Enrico ^a   Monaco, Annalisa ^a   Procaccini, Laura ^a   Mummolo, Stefano ^a   Gatto, Roberto ^a   Tetè, Stefano ^b   Baldini, Alberto ^c   Tecco, Simona ^a   Marzo, Giuseppe ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Adipocytokines; Metabolic syndrome; Oxidative stress; Periodontitis

Indexed keywords

ADVANCED GLYCATION END PRODUCT; GLUCAGON LIKE PEPTIDE 1; GOMISIN; INSULIN; INTERLEUKIN 6; LEPTIN; MATRIX METALLOPROTEINASE; MINOCYCLINE; PEPTIDE YY; PROANTHOCYANIDIN; PROSTAGLANDIN E2; REACTIVE OXYGEN METABOLITE; S NITROSOGLUTATHIONE; TEMPOL; TETRACYCLINE; THYMOQUINONE; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; APOPTOSIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BACTERIAL COLONIZATION; CARDIOVASCULAR DISEASE; CELL ACTIVATION; CYTOKINE RELEASE; DIABETIC KETOACIDOSIS; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DIET; DISEASE ASSOCIATION; ENDOTHELIUM CELL; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; MEDIATOR RELEASE; METABOLIC SYNDROME X; MOUTH HYGIENE; NEUTROPHIL CHEMOTAXIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OXIDATIVE STRESS; PATHOGENESIS; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; PROTEIN BLOOD LEVEL; REVIEW; SYSTEMATIC REVIEW (TOPIC);

EID: 84866559384     PISSN: None     EISSN: 17437075     Source Type: Journal    
DOI: 10.1186/1743-7075-9-88     Document Type: Review

References (123)

1. Association beteen metabolic syndrome and periodontal disease. Andriankaja OM, Sreenivasa S, Dunford R, DeNardin E, Aust Dent J 2010 55 252 259 10.1111/j.1834-7819.2010.01231.x 20887511
2. Diagnosis of periodontal disease. Armitage GC, J periodontology 2003 74 1237 1247
3. Ethnic origin and alveolar bone loss in Israeli adults. Zadik Y, Bechor R, Shochat Z, Galor S, Refuat Hapeh Vehashinayim 2008 25 2 19 22 19263864
4. The American Academy of Periodontology, Proceedings of the World Workshop in Clinical Periodontics The American Academy of Periodontology, Chicago 1989 /23 I/24
5. Host tissue response in chronic periodontal disease. 1. The normal periodontium and clinical manifestations of dental and periodontal disease in the marmoset. Ammons WF, Schectman LR, Page RC, J Periodontal Res 1972 7 2 131 143 10.1111/j.1600-0765.1972.tb00638.x 4272039
6. Pathogenesis of inflammatory periodontal disease. A summary of current work. Page RC, Schroeder HE, Laboratory investigation; a journal of technical methods and pathology 1976 34 3 235 249 23082164
7. Flossing for the management of periodontal diseases and dental caries in adults. In Johnson, Trevor M. Sambunjak D, Nickerson JW, Poklepovic T, Johnson TM, Imai P, Tugwell P, Worthington HV, Cochrane Database Syst Rev 2011 7 12 D008829
8. Efficacy of a Fluoridated Hydrogen Peroxide-Based Mouthrinse for the Treatment of Gingivitis: A Randomized Clinical Trial. Hasturk H, Nunn M, Warbington M, Van Dyke TE, J Periodontol 2004 75 1 57 65 10.1902/jop.2004.75.1. 57 15025217 (Pubitemid 38312770)
9. Emerging role of PPAR-/ in inflammatory process associated to experimental periodontitis. Di Paola R, Briguglio F, Paterniti I, Mazzon E, Oteri G, Militi D, Cordasco G, Cuzzocrea S, Mediators Inflamm 2011 7 87 159
10. Interleukin-21 Expression and its Association with Pro-Inflammatory Cytokines in Untreated Chronic Periodontitis Patients. Dutzan N, Vernal R, Vaque JP, García-Sesnich J, Hernandez M, Abusleme L, Dezerega A, Gutkind JS, Gamonal J, J Periodontol 2012 83 7 948 954 10.1902/jop.2011.110482 22181687
11. Interleukin-4 and interleukin-13 inhibit the expression of leukemia inhibitory factor and interleukin-11 in fibroblasts. Souza PP, Palmqvist P, Lundberg P, Lundgren I, Hänström L, Souza JA, Conaway HH, Lerner UH, Mol Immunol 2012 49 4 601 610 10.1016/j.molimm.2011.10.009 22142941
12. Role of insulin resistance in human disease. Reaven GM, Banting lecture 1988, Diabetes 1998 37 1595 1607
13. Metabolic Syndrome: what are risks for humans? Abhishek G, Gupta V, BioScience Trend 2010 4 204 212
14. Relationship between plasma resistin concentrations, inflammatory chemokines and components of the Metabolic Syndrome in adults. Aquilante CL, Kosmiski LA, Knusten SD, Zineh I, Metabolism 2008 5 Suppl 4 494 501 (Pubitemid 351317963)
15. Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP), JAMA 2001 285 19 2486 2497 10.1001/jama.285.19.2486 11368702
16. Metabolic Syndrome, http://www.heart.org/HEARTORG/Conditions/More/ MetabolicSyndrome/About-Metabolic-Syndrome-UCM-301920-Article.jsp
17. Metabolic Syndrome and Periodontitis: Is Oxidative Stress a Common Link? Bullon P, Morillo JM, Ramirez-Tortosa MC, Quiles JL, Newman HN, Battino M, J Dent Res 2009 88 503 518 10.1177/0022034509337479 19587154
18. Metabolic syndrome: what is the clinical usefulness? Kahn R, Lancet 2008 371 1891 1893
19. The metabolic syndrome: is this diagnosis necessary? Reaven GM, Am J Clin Nutr 2006 83 1237 1247 erratum in Am J Clin Nutr 2006, 84:1253 16762930 (Pubitemid 44713049)
20. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Ceriello A, Motz E, Arterioscler Thromb Vasc Biol 2004 24 Suppl5 816 823 14976002 (Pubitemid 38620857)
21. The role of reactive oxygen and antioxidant species in periodontal tissue destruction. Iain LC C, Matthews JB, Periodontol 2007 43 160 232 10.1111/j.1600-0757.2006.00178.x
22. Efficacy of Er:YAG laser in the treatment of chronic periodontitis: systematic review and meta-analysis. Sgolastra F, Petrucci A, Gatto R, Monaco A, Lasers Med Sci 2011 27 3 661 673 21553003
23. Free radicals, antioxidants and human disease: where are we now? Halliwell B, Gutteridge JMC, Cross CE, J Lab Clin Med 1992 119 598 617 1593209
24. Oxidative stress markers, C-reactive protein and heat shock protein 70 levels in subjects with metabolic syndrome. Armutcu F, Ataymen M, Atmaca H, Gurel A, Clin Chem Lab Med 2008 46 Suppl 6 785 790 18601599 (Pubitemid 351821641)
25. Obesity and body fat distribution induce endothelial dysfunction by oxidative stress: protective effect of vitamin C. Perticone F, Ceravolo R, Candigliota M, Ventura G, Iacopino S, Sinopoli F, Mattioli PL, Diabetes 2001 50 Suppl 1 159 165 11147782 (Pubitemid 32047995)
26. Protection against oxidative stress-induced insulin resistance in rat L6 muscle cells by micromolar concentrations of -lipoic acid. Maddux BA, See W, Lawrence JC Jr, Goldfine AL, Goldfine ID, Evans JL, Diabetes 2001 50 404 410 10.2337/diabetes.50.2.404 11272154 (Pubitemid 32127299)
27. Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity. Hansel B, Giral P, Nobecourt E, Chantepie S, Bruckert E, Chapman MJ, et al. J Clin Endocrinol Metab 2004 89 4963 4971 10.1210/jc.2004-0305 15472192 (Pubitemid 39391435)
28. Oxidative stress in metabolic syndrome. Sharma P, Mishra S, Ajmera P, Mathur S, Indian J Clin Biochem 2005 20 145 149 10.1007/BF02893061 (Pubitemid 40363623)
29. Insulin resistance and postprandial hyperglycemia the bad companionsin natural history of diabetes: effects on health of vascular tree. Di Filippo C, Verza M, Coppola L, Rossi F, DAmico M, Marfella R, Curr Diabetes Rev 2007 3 268 273 10.2174/157339907782330012 18220686 (Pubitemid 350111111)
30. Inflammatory mechanisms in the regulation of insulin resistance. Tilg H, Moschen AR, Mol Med 2008 14 222 231 18235842 (Pubitemid 351481853)
31. Intramuscular heat shock protein 72 and heme oxygenase-1 mRNA are reduced in patients with type 2 diabetes: evidence that insulin resistance is associated with a disturbed antioxidant defence mechanism. Bruce CR, Carey AL, Hawley JA, Febbraio MA, Diabetes 2003 52 2338 2345 10.2337/diabetes.52.9.2338 12941774 (Pubitemid 37059505)
32. Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis. Koyama H, Shoji T, Yokoyama H, Motoyama K, Mori K, Fukumoto S, et al. Arterioscler Thromb Vasc Biol 2005 25 2587 2593 10.1161/01.ATV.0000190660.32863.cd 16224056 (Pubitemid 43732283)
33. A Role for Non-Antimicrobial Actions of Tetracyclines in Combating Oxidative Stress in Periodontal and Metabolic Diseases: A Literature Review. Soory M, The Open Dentistry Journal 2008 2 5 12 10.2174/1874210600802010005 19088876
34. Tetracyclines: Non antibiotic properties and their implications. Sapadin AN, Fleischmajer R, J Am Acad Dermatol 2006 54 258 265 10.1016/j.jaad.2005.10. 004 16443056 (Pubitemid 43144395)
35. Osteoblastic responses to LPS, glucose-oxidised LDL and minocycline: therapeutic targets for periodontal and cardiometabolic diseases. Tilakaratne A, Soory M, Recent Pat Endocr Metab Immune Drug Discov 2012 6 1 73 84 10.2174/187221412799015281 22280224
36. Effects of the antioxidant agent tempol on periapical lesions in rats with doxorubicin-induced cardiomyopathy. Brilhante Wolle CF, de Aguiar Zollmann L, Etges A, Vitalis GS, Leite CE, Campos MM, J Endod 2012 38 2 191 195 10.1016/j.joen.2011.11.007 22244634
37. Anti-inflammatory effect of heme oxygenase-1 toward Porphyromonas gingivalis lipopolysaccharide in macrophages exposed to gomisins A, G, and J. Ryu EY, Park SY, Kim SG, da Park J, Kang JS, Kim YH, Seetharaman R, Choi YW, Lee SJ, J Med Food 2011 14 12 1519 1526 10.1089/jmf.2011.1656 22145771
38. Cranberry Proanthocyanidins: Natural Weapons against Periodontal Diseases. Feghali K, Feldman M, La VD, Santos J, Grenier D, J Agric Food Chem 2011 29 7320344
39. Preventive effects of thymoquinone in a rat periodontitis model: a morphometric and histopathological study. Ozdemir H, Kara MI, Erciyas K, Ozer H, Ay S, J Periodontal Res 2012 47 1 74 80 10.1111/j.1600-0765.2011.01406.x 21992581
40. S-nitrosoglutathione decreases inflammation and bone resorption in experimental periodontitis in rats. de Menezes AM, de Souza GF, Gomes AS, de Carvalho Leitão RF, de Albuquerque Ribeiro R, de Oliveira MG, de Castro Brito GA, J Periodontol 2012 83 4 514 521 10.1902/jop.2011.110332 21910597
41. Schisandra chinensis -iso-cubebenol induces heme oxygenase-1 expression through PI3K/Akt and Nrf2 signaling and has anti-inflammatory activity in Porphyromonas gingivalis lipopolysaccharide-stimulated macrophages. Park SY, da Park J, Kim YH, Kim Y, Choi YW, Lee SJ, Int Immunopharmacol 2011 11 11 1907 1915 10.1016/j.intimp.2011.07.023 21840424
42. Dentists, diabetes and periodontitis. Bjelland S, Bray P, Gupta N, et al. Austr Dent Journ 2002 47 202 207 10.1111/j.1834-7819.2002.tb00329.x
43. Markers of systemic bacterial exposure in periodontal disease and cardiovascular disease risk: a systematic review and meta-analysis. Mustapha IZ, Debrey S, Oladubu M, Ugarte R, J Periodontol 2007 78 12 2289 2302 10.1902/jop.2007.070140 18052701
44. The effect of antimicrobial periodontal treatment on circulating tumor necrosis factor-alpha and glycated hemoglobin level in patients with type 2 diabetes. Iwamoto Y, Nishimura F, Nakagawa M, Sugimoto H, Shikata K, Makino H, et al. J Periodontol 2001 72 774 778 10.1902/jop.2001.72.6.774 11453240 (Pubitemid 33606560)
45. Treatment of periodontal disease in diabetics reduces glycated hemoglobin. Grossi SG, Skrepcinski FB, DeCaro T, Robertson DC, Ho AW, Dunford RG, et al. J Periodontol 1997 68 713 719 10.1902/jop.1997.68.8.713 9287060 (Pubitemid 27357899)
46. Possible involment of advanced glycation end products in periodontal diseases. Pietropaoli D, Tatone C, DAlessandro, Monaco A, B Int Journ of immunopathol and pharmacol 2010 23 Suppl 3 683 691
47. Expression of the receptor of advanced glycation end products in gingival tissues of type 2 diabetes patients with chronic periodontal disease: a study utilizing immunohistochemistry and RT-PCR. Katz J, Bhattacharyya I, Farkhondeh-Kish F, Perez FM, Caudle RM, Heft MW, J Clin Periodontol 2005 32 40 44 10.1111/j.1600-051X.2004.00623.x 15642057 (Pubitemid 40187424)
48. Advanced glycation end products and the kidney. Bohlender JM, Franke S, Stein G, Wolf G, Am J Physiol Renal Physiol 2005 289 645 F659 10.1152/ajprenal.00398.2004 16159899 (Pubitemid 41324185)
49. Advanced glycation end products stimulate an enhanced neutrophil respiratory burst mediated through the activation of cytosolic phospholipase A2 and generation of arachidonic acid. Wong RK, Pettit AI, Quinn PA, et al. Circulation 2003 108 1858 1864 10.1161/01.CIR.0000089372.64585.3B 12963645 (Pubitemid 37296096)
50. Periodontitis and diabetes: a two way relationship. Preshaw PM, Alba AL, Herrera D, et al. Diabetologia 2012 55 21 31 10.1007/s00125-011-2342-y 22057194
51. Oxidative and inflammatory status in type 2 diabetes patients with periodontitis. Allen EM, Mattews JB, OHalloran DJ, et al. J Clin Peridontol 2011 38 894 901 10.1111/j.1600-051X.2011.01764.x
52. The role of hyperglycemia in mechanisms of exacerbated inflammatory responses within the oral cavity. Amir J, Waite M, et al. Cell Immunol 2011 272 45 52 10.1016/j.cellimm.2011.09.008 21996642
53. Decursin, an Active Compound Isolated from Angelica gigas, Inhibits Fat Accumulation, Reduces Adipocytokine Secretion and Improves Glucose Tolerance in Mice Fed a High-Fat Diet. Hwang JT, Kim SH, Hur HJ, Kim HJ, Park JH, Sung MJ, Yang HJ, Ryu SY, Kim YS, Cha MR, Kim MS, Kwon DY, Phytother Res 2012 26 5 633 638 10.1002/ptr.3612 21972114
54. Oxidative stress, systemic inflammation and severe periodontitis. DAiuto F, Nibali L, Parkar M, Patel K, et al. J Dent Res 2010 89 1241 1246 10.1177/0022034510375830 20739696
55. Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction? Evans JL, Goldfine ID, Maddux BA, Grodsky GM, Diabetes 2003 52 1 8 10.2337/diabetes.52.1.1 12502486 (Pubitemid 36042100)
56. Periodontitis and systemic inflammation: control of the local infection is associated with a reduction in serum inflammatory markers. DAiuto F, Parkar M, Andreou G, et al. J Dent Res 2004 83 156 160 10.1177/154405910408300214 14742655 (Pubitemid 41713801)
57. Heterogeneity of systemic inflammatory responses to periodontal therapy. Behle JH, Sedaghatfar MH, Demmer RT, et al. J Clin Periodontol 2009 36 287 294 10.1111/j.1600-051X.2009.01382.x 19426174
58. Short-term effects of intensive periodontal therapy on serum inflammatory markers and cholesterol. DAiuto F, Nibali L, Parkar M, Suvan J, Tonetti MS, J Dent Res 2005 84 269 273 10.1177/154405910508400312 15723869 (Pubitemid 43822036)
59. Results from the Periodontitis and Vascular Events (PAVE) Study: a pilot multicentered, randomized, controlled trial to study effects of periodontal therapy in a secondary prevention model of cardiovascular disease. Offenbacher S, Beck JD, Moss K, et al. J Periodontol 2009 80 190 201 10.1902/jop.2009.080007 19186958
60. Effect of non-surgical periodontal therapy on clinical and immunological response and glycaemic control in type 2 diabetic patients with moderate periodontitis. Navarro-Sanchez AB, Faria-Almeida R, Bascones-Martinez A, J Clin Periodontol 2007 34 835 843 10.1111/j.1600-051X.2007.01127.x 17850602
61. Periodontitis-atherosclerosis syndrome: an expanded model of pathogenesis. Offenbacher S, Madianos PN, Champagne CM, Southerland JH, Paquette DW, Williams RC, et al. J Periodont Res 1999 34 346 352 10.1111/j.1600-0765. 1999.tb02264.x 10685359
62. Inflammation and atherosclerosis. Libby P, Ridker P, Maseri A, Circulation 2002 105 1135 1143 10.1161/hc0902.104353 11877368 (Pubitemid 34212626)
63. Effects of Periodontal Therapy on Systemic Markers of Inflammation in Patients With Metabolic Syndrome: A Controlled Clinical Trial. Lápez NJ, Quintero A, Casanova PA, Ibieta CI, Baelum V, Lápez R, J Periodontol 2012 83 3 267 278 10.1902/jop.2011.110227 21749167
64. Obesity, inflammation and periodontal disease. Pischon N, Heng JP, et al. J Dent Res 2007 86 suppl. 5 400 409 17452558
65. Two defects contribute to hypothalamic leptin resistance in mice with diet induced obesity. El-Haschimi K, Pierroz DD, Hileman SM, Bjorbaek C, Flier JS, J Clin Invest 2000 105 1827 1832 10.1172/JCI9842 10862798 (Pubitemid 30421764)
66. Periodontal inflammation and Insulin resistance, lessons from obesity. Nishimura F, Murayama Y, J Dent Res 2001 80 (suppl.8 1690 1694 11669476 (Pubitemid 32931340)
67. Increased adipose tissue expression of tumor necrosis factor-at in human obesity and insulin resistance. Hotamisligil GS, Amer P, Caro JF, Atkinson RL, Spiegelman BM, J Clin Invest 1995 95 2409 2415 10.1172/JCI117936 7738205
68. Insulin resistance in patients with cancer. Lundholm K, Holm G, Schersten T, Cancer Res 1997 38 4665 4670
69. Interleukin-6 (IL-6) induces insulin resistance in 3 T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects. Rotter V, Nagaev I, Smith U, J Biol Chem 2003 278 45777 45784 10.1074/jbc.M301977200 12952969 (Pubitemid 37432722)
70. Protection from obesity-induced insulin resistance in mice lacking TNF-at function. Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS, Nature 389 610 614 9335502
71. Insulin/IGF-1 and TNF-ot stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways. Rui L, Aguirre V, Kim JK, Shulman GI, Lee A, Corbould A, et al. J Clin Invest 2001 107 181 189 10.1172/JCI10934 11160134 (Pubitemid 32096834)
72. Insulin signaling is inhibited by micromolar concentrations of H202. Evidence for a role of H202 in tumor necrosis factor a-mediated insulin resistance. Hansen LL, Ikeda Y, Olsen GS, Busch AK, Mosthaaf L, J Biol Chem 1999 274 25078 25084 10.1074/jbc.274.35.25078 10455187 (Pubitemid 29404719)
73. Increased physical activity decreases periodontitis risk in men. Merchant AT, Pitiphat W, Rimm EB, Joshipura K, Eur J Epidemiol 2003 18 891 898 10.1023/A:1025622815579 14561049 (Pubitemid 37169026)
74. Leisure-time physical activity and reduced plasma levels of obesityrelated inflammatory markers. Pischon T, Hankinson SE, Hotamisligil GS, Rifai N, Rimm EB, Obes Res 2003 11 1055 1064 10.1038/oby.2003.145 12972675 (Pubitemid 41151582)
75. Periodontitis and three health-enhancing behaviors: maintaining normal weight, engaging in recommended level of exercise, and consuming a high-quality diet. Al-Zahrani MS, Borawski EA, Bissada NF, J Periodontol 2005 76 1362 1366 10.1902/jop.2005.76.8.1362 16101370 (Pubitemid 41245782)
76. Interleukin-1 genetic association with periodontitis in clinical practice. McDevitt MJ, Wang HY, Knobelman C, et al. J Periodontology 2000 71 156 163 10.1902/jop.2000.71.2.156
77. The association between periodontal disease, physical activity and healthy diet among adults in Jordan. Bawadi HA, Khader YS, Haroun TF, Al-Omari M, Tayyem RF, J Periodontal Res 2011 46 1 74 81 10.1111/j.1600-0765.2010.01314.x 20860591
78. Systemic effects of periodontitis: epidemiology of periodontal disease and cardiovascular disease. Beck JD, Offenbacher S, J Periodontol 2005 76 Suppl11 2089 2100 16277581 (Pubitemid 41748958)
79. Systemic markers of inflammation in periodontitis. Loos BG, J Periodontol 2005 76 Suppl11 2106 2115 16277583 (Pubitemid 41748960)
80. Periodontal treatment decreases plasma oxidized LDL level and oxidative stress. Tamaki N, Tomofuji T, Ekuni D, Yamanaka R, Morita M, Clin Oral Investig 2011 15 6 953 958 10.1007/s00784-010-0458-y 20717698
81. The relationship between periodontal condition and serum levels of resistin and adiponectin in elderly Japanese. Furugen R, Hayashida H, Yamaguchi N, Yoshihara A, Ogawa H, Miyazaki H, et al. J Clin Periodontol 2008 43 556 562
82. Serum levels of resistin and adiponectin in women with periodontitis: the Hisayama study. Saito T, Yamaguchi N, Shimazaki Y, Hayashida H, Yonemoto K, Doi Y, et al. J Dent Res 2008 87 319 322 10.1177/154405910808700416 18362311
83. Gingival crevicular fluid leptin levels in periodontitis patients with long-term and heavy smoking. Bozkurt FY, Yetkin Ay Z, Sutcu R, Deliba N, Demirel R, J Periodontol 2006 77 634 640 10.1902/jop.2006.050277 16584344 (Pubitemid 44725048)
84. Association between chronic periodontal disease and obesity: a systematic review an meta-analysis. Chaffee BW, Weston SJ, J Periodontol 2010 12 1708 1724
85. Response to Periodontal Therapy in Subjects Who Had Weight Loss Following Bariatric Surgery and Obese Counterparts: A Pilot Study. Lakkis D, Bissada NF, Saber A, Khaitan L, Palomo L, Narendran S, Al-Zahrani MS, J Periodontol 2011 83 6 684 689 22014172
86. The role of obesity as a modifying factor in patients undergoing non-surgical periodontal therapy. Zouza EP, Barroso EM, et al. J Periodontol 2010 82 676 682 21073330
87. Association between overweight/obesity and periodontitis in adults. A systematic review. Suvan J, DAiuto F, Moles DR, Petrie A, Donos N, Obes Rev 2011 12 5 381 e404 10.1111/j.1467-789X.2010.00808.x 21348914
88. Neural and humoral changes associated with the adjustable gastric band: insights from a rodent model. Kampe J, Stefanidis A, Lockie SH, Brown WA, Dixon JB, Odoi A, Spencer SJ, Raven J, Oldfield BJ, Int J Obes (Lond) 2012 27
89. Plasma neuropeptide Y (NPY) and alpha-melanocyte stimulating hormone (a-MSH) levels in patients with or without hypertension and/or obesity: a pilot study. Baltazi M, Katsiki N, Savopoulos C, Iliadis F, Koliakos G, Hatzitolios AI, Am J Cardiovasc Dis 2011 1 1 48 59 22254185
90. Chemerin and adiponectin contribute reciprocally to metabolic syndrome. Chu SH, Lee MK, Ahn KY, Im JA, Park MS, Lee DC, Jeon JY, Lee JW, PLoS One 2012 7 4 34710 10.1371/journal.pone.0034710 22509348
91. Induction of insulin resistance by the adipokines resistin, leptin, PAI-1 and RBP4 in human megakaryocytes. Gerrits AJ, Gitz E, Koekman CA, Visseren FL, van Haeften TW, Akkerman JW, Haematologica 2012 97 8 1149 1157 10.3324/haematol.2011.054916 22491740
92. The impact of extended care on the long-term maintenance of weight loss: a systematic review and meta-analysis. Ross Middleton KM, Patidar SM, Perri MG, Obes Rev 2011 13 6 509 517 22212682
93. Relationship between Periodontal Diseases and Preterm Birth: Recent Epidemiological and Biological Data. Huck O, Tenenbaum H, Davideau JL, J Pregnancy 2011 16 46 54
94. Impact of the components of metabolic syndrome on oxidative stress and enzymatic antioxidant activity in essential hypertension. Abdilla N, Tormo MC, Fabia MJ, Chaves FJ, Saez G, Redon J, J Hum Hypertens 2007 21 suppl.1 68 75 17066087 (Pubitemid 44921821)
95. Inadequate cytoplasmic antioxidant enzymes response contributes to the oxidative stress in human hypertension. Chaves FJ, Mansego ML, Blesa S, Gonzalez-Albert V, Jimenez J, Tormos MC, Espinosa O, Giner V, Iradi A, Saez G, Redon J, Am J Hypertens 2007 20 supp 1 62 69 17198913 (Pubitemid 46014061)
96. Diagnosis, prevention, and intervention for the metabolic syndrome. Scott CL, Am J Cardiol 2003 92 35i 42i 10.1016/S0002-9149(03)00507-1 12867253 (Pubitemid 36831113)
97. Metabolic syndrome: pathogenesis, medical care and dental implications. Arthur H, Friedlander DMD, Jane Weinreb MD, Clinical pactice 2007 138 179 187
98. Association between periodontal disease and left ventricle mass in essential hypertension. Angeli F, Verdecchia P, Pellegrino C, Pellegrino RG, Pellegrino G, Prosciutti L, et al. Hypertension 2003 41 488 492 10.1161/01.HYP.0000056525.17476.D7 12623948 (Pubitemid 36314621)
99. Periodontal disease and Incidence of Hypertension in the Health Professionals Follow-Up Study. Rivas-Tumanyan S, Spiegelman D, Curhan GC, Forman JP, Joshipura KJ, Am J Hypertens 2012 25 7 770 776 10.1038/ajh.2012.32 22476024
100. Periodontal Disease, Hypertension and Blood Pressure Among Older Adults in Puerto Rico. Rivas-Tumanyan S, Campos M, Zevallos JC, Joshipura KJ, J Periodontol 2012 23075433
101. Periodontal infection is associated with endothelial dysfunction in healthy subjects and hypertensive patients. Higashi Y, Goto C, Jitsuiki D, Umemura T, Nishioka K, Hidaka T, Takemoto H, Nakamura S, Soga J, Chayama K, Yoshizumi M, Taguchi A, Hypertension 2008 51 2 446 453 10.1161/HYPERTENSIONAHA. 107.101535 18039979 (Pubitemid 351156431)
102. Compromised GCF total antioxidant capacity in periodontitis. Cause or effect? Chapple IL, Brock GR, Milaward MR, et al. J Clin Periodontol 2007 34 103 110 17214737
103. Local and systemic antioxidant capacity in periodontitis and health. Brock GR, Matthews JB, Butterworth CJ, Chapple ILC, J Clin Periodontol 2004 31 515 521 10.1111/j.1600-051X.2004.00509.x 15191586 (Pubitemid 38901220)
104. Poor oral health is associated with coronary heart disease and elevated systemic inflammatory and haemostatic factors. Montebugnoli L, Servidio D, Miaton RA, Prati C, Tricoci P, Melloni C, J Clin Periodontol 2004 31 25 29 10.1111/j.0303-6979.2004.00432.x 15058371 (Pubitemid 38623827)
105. Proinflammatory and oxidative stress markers in patients with periodontal disease. Borges I Jr, Moreira EA, Filho DW, de Oliveira TB, da Silva MB, Fröde TS, Mediators Inflamm 2007 4 57 94
106. Advanced glycation endproducts stimulate osteoblast apoptosis via the MAP kinase and cytosolic apoptotic pathways. Alikhani M, Alikhani Z, Boyd C, MacLellan CM, Raptis M, Liu R, et al. Bone 2007 40 345 353 10.1016/j.bone.2006. 09.011 17064973 (Pubitemid 46054556)
107. Treatment of chronic periodontitis decreases serum prohepcidin levels in patients with chronic kidney disease. Vilela EM, Bastos JA, Fernandes N, Ferreira AP, Chaoubah A, Bastos MG, Clinics (Sao Paulo) 2011 66 657 662 10.1590/S1807-59322011000400022
108. Treatment of periodontitis and endothelial function. Tonetti MS, D Aiuto F, Nibali L, Donald A, Storry C, Parkar M, et al. N Engl J Med 2007 356 911 920 10.1056/NEJMoa063186 17329698 (Pubitemid 46339910)
109. Association between chronic periodontal disease and obesity: a systematic review and meta-analysis. Chaffee BW, Wetson SJ, J Periodontol 2010 81 1708 1724 10.1902/jop.2010.100321 20722533
110. Metabolic syndrome, periodontal infection and dental caries. Timonen P, Niskanen M, Suominen-Taipale L, et al. J Dent Res 2010 89 1068 1073 10.1177/0022034510376542 20647498
111. Glycemix index of foods:a physiological basis for carbohydrate exachange. Jenkins DJ, Wolever TM, Taylor RH, et al. Am J Clin Nutr 1981 34 362 366 6259925 (Pubitemid 11159124)
112. The glycemic index: physiological mechanisms relating to obesity, diabetes and cardiovascular disease. Ludvig DS, JAMA 2002 287 2414 2423 10.1001/jama.287.18.2414 11988062
113. Oral Infection, hyperglycemia and endothelial dysfunction. Janket S-J, Jones JA, Meurman JH, Baird AE, Van Dyke TE, Oral Surg, Oral Med, Oral Pathol, Oral Radiol and Endodontology 2008 105 suppl 2 173 179
114. Effects of counterregulatory hormones in a high glycemic index diet. Brotman DJ, JAMA 2002 14 6 288 695
115. Dietary carbohydrates, physical inactivity, obesity, and the metabolic syndrome as predictors of coronary heart disease. Liu S, Manson JE, Curr Opin Lipidol 2001 12 395 404 10.1097/00041433-200108000-00005 11507324 (Pubitemid 32675500)
116. Association of edentulism and diet and nutrition in US adults. Nowjack-Raymer RE, Sheiham A, J Dent Res 2003 82 123 126 10.1177/ 154405910308200209 12562885 (Pubitemid 41764123)
117. Nutrition as a mediator in the relation between oral and systemic disease: associations between specific measures of adult oral health and nutrition outcomes. Ritchie CS, Joshipura K, Hung HC, Douglass CW, Crit Rev Oral Biol Med 2002 13 291 300 10.1177/154411130201300306 12090466 (Pubitemid 34791211)
118. How dentition status and masticatory function affect nutrient intake. Krall E, Hayes C, Garcia R, JADA 1998 129 1261 1269 9766107 (Pubitemid 128452841)
119. The effects of mandibular two-implant overdentures on nutrition in elderly edentulous individuals. Morais JA, Heydecke G, Pawliuk J, Lund JP, Feine JS, J Dent Res 2003 82 53 58 10.1177/154405910308200112 12508046
120. Wynn RL, Meiller TF, Crossley HL, Drug information for dentistry: Oral medicine for medically-compromised patients and specific oral conditions Lexi-Comp, Hudson, Ohio 9 2003
121. Low-dose aspirin for secondary cardiovascular prevention: cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuatio: review and meta-analysis. Burger W, Chemnitius JM, Kneissl GD, Rucker G, J Intern Med 2005B 257 399 414 10.1111/j.1365-2796.2005.01477.x (Pubitemid 40604544)
122. Diabetes mellitus: relevance to dental treatment. Vernillo AT, Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001 91 263 270 10.1067/moe.2001.114002 11250621 (Pubitemid 33608843)
123. Dental considerations for the treatment of patients with diabetes mellitus. Vernillo AT, JADA 2003 134 24s 33s 18196670